For the first time, a randomized controlled clinical trial has demonstrated that an intensive lifestyle intervention, without drugs, may significantly improve cognition and function in many patients with mild cognitive impairment or early dementia due to Alzheimer’s disease. This multisite clinical study is published in the leading peer-reviewed Alzheimer’s translational research journal, Alzheimer’s Research and Therapy.
With better clinical outcomes, larger cost savings, bigger changes in lifestyle, and higher adherence and engagement, lifestyle medicine is reimbursed by Blue Shield of California, Medicare, Aetna, and many other commercial payers.
Press Release with Blue Shield of CaliforniaReimbursement
Medicare
Blue Shield of California
Aetna
Join our list to receive sample recipes, our latest research and related resources!